Experience with a measles vaccine manufactured in India.
Five hundred and twenty seven children between 7 months and 2 years of age were vaccinated with measles vaccine manufactured by the Serum Institute of India. The sero-conversion rate in children who had no antibodies previous to vaccination was 98.4% as tested in HI. Ninety per cent of children who had pre-vaccination measles antibodies showed a two-fold or more rise in HI antibodies. The side reactions of the vaccine were negligible.
Shaikh
N
N
National Institute of Virology, Pune.
Raut
S K
SK
Bedekar
S S
SS
Phadke
M A
MA
Banerjee
K
K
D000914:Antibodies, Viral / Q000097:blood*; D002675:Child, Preschool; D006801:Humans; D007194:India; D007223:Infant; D008458:Measles Vaccine / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*
D000914:Antibodies, Viral; D008458:Measles Vaccine